Daniela Vullo Selected Research

Anions

12/2018	Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae.
1/2017	Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics.
1/2017	Anion inhibitors of the β-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella tularensis.
1/2016	Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
11/2015	Anion inhibition studies of the dandruff-producing fungus Malassezia globosa β-carbonic anhydrase MgCA.
4/2015	Dipotassium-trioxohydroxytetrafluorotriborate, K₂[B₃O₃F₄OH], is a potent inhibitor of human carbonic anhydrases.
3/2007	Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions.
2/2005	Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates.
2/2005	Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate.
12/2004	Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Vullo Research Topics

Disease

102	Neoplasms (Cancer) 12/2022 - 03/2003
9	Glaucoma 05/2020 - 02/2002
8	Dandruff 05/2019 - 04/2012
6	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2011
5	Malaria 12/2018 - 09/2014
5	Melioidosis 12/2018 - 01/2017
5	Hypoxia (Hypoxemia) 01/2018 - 07/2010
4	Obesity 11/2019 - 02/2004
4	Infections 12/2016 - 02/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 05/2006
4	Carcinogenesis 10/2014 - 11/2005
4	Periodontitis 09/2014 - 07/2013
3	Rheumatoid Arthritis 01/2019 - 01/2017
3	Dehydration (Water Stress) 10/2016 - 11/2010
3	Epilepsy (Aura) 05/2009 - 08/2007
2	Tularemia 01/2017 - 01/2017
2	Seizures (Absence Seizure) 01/2016 - 05/2009
2	Disease Progression 02/2004 - 03/2003
1	Cholera 12/2019
1	Seborrheic Dermatitis 05/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2017
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Amnesia (Dissociative Amnesia) 01/2017
1	Melanoma (Melanoma, Malignant) 12/2016
1	Mycoses (Diseases, Fungus) 12/2016
1	Cognitive Dysfunction 01/2016
1	Intellectual Disability (Idiocy) 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Nervous System Diseases (Neurological Disorders) 12/2015
1	Ascariasis 09/2015

Drug/Important Bio-Agent (IBA)

97	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2022 - 05/2003
62	IsoenzymesIBA 12/2016 - 02/2002
61	Protein Isoforms (Isoforms)IBA 01/2022 - 08/2003
54	SulfonamidesIBA 02/2017 - 03/2003
40	EnzymesIBA 05/2019 - 05/2003
23	Carbonic Anhydrase InhibitorsIBA 01/2019 - 03/2003
15	ZincIBA 10/2014 - 05/2003
14	Pharmaceutical PreparationsIBA 10/2020 - 04/2006
13	Carbonic Anhydrase IXIBA 02/2017 - 03/2003
11	BenzenesulfonamidesIBA 12/2019 - 03/2007
11	AnionsIBA 12/2018 - 10/2003
9	Acetazolamide (Diamox)FDA LinkGeneric 10/2020 - 03/2003
6	sulfamic acid (ammonium sulfamate)IBA 02/2017 - 12/2003
6	Proteins (Proteins, Gene)FDA Link 02/2017 - 03/2005
5	Amino Acids FDA Link 12/2018 - 08/2007
5	AminesIBA 12/2018 - 08/2007
5	Sulfanilamide FDA Link 01/2017 - 02/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 02/2014
4	dorzolamide (Trusopt)FDA LinkGeneric 05/2015 - 03/2003
4	CarbohydratesIBA 10/2014 - 04/2007
3	CoumarinsIBA 01/2017 - 11/2014
3	Hydro-Lyases (Dehydratases)IBA 01/2016 - 01/2007
2	SLC-0111IBA 01/2019 - 01/2017
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 01/2017
2	dipotassium trioxohydroxytetrafluorotriborateIBA 12/2016 - 04/2015
2	LigandsIBA 03/2016 - 04/2014
2	isoquinolineIBA 01/2016 - 03/2010
2	Biological ProductsIBA 12/2013 - 05/2011
2	Anticonvulsants (Antiepileptic Drugs)IBA 04/2012 - 05/2009
2	Phenol (Carbolic Acid)FDA Link 03/2011 - 10/2009
2	GlycoconjugatesIBA 03/2008 - 04/2007
2	SugarsIBA 03/2008 - 05/2003
2	Protons (Proton)IBA 01/2007 - 09/2006
2	Methazolamide FDA LinkGeneric 05/2003 - 03/2003
2	Ethoxzolamide (Ethamide)FDA Link 05/2003 - 03/2003
2	brinzolamide (Azopt)FDA Link 05/2003 - 03/2003
1	Monoclonal AntibodiesIBA 12/2022
1	Carbon MonoxideIBA 01/2019
1	Carboxylic AcidsIBA 12/2017
1	3-nitrobenzoic acidIBA 12/2017
1	BiguanidesIBA 02/2017
1	Tirapazamine (SR 4233)IBA 02/2017
1	Chlorambucil (Leukeran)FDA Link 02/2017
1	Phenformin (Fenformin)IBA 02/2017
1	Temozolomide (Temodar)FDA LinkGeneric 02/2017
1	Sulindac (Copal)FDA LinkGeneric 01/2017
1	Cyclooxygenase InhibitorsIBA 01/2017
1	SaccharinIBA 01/2017
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2017
1	Diclofenac (SR 38)FDA LinkGeneric 01/2017
1	benzamideIBA 01/2017
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2017
1	KetorolacIBA 01/2017
1	Ketoprofen (Orudis)FDA LinkGeneric 01/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2017
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2017
1	Insulin-Like PeptidesIBA 12/2016
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2016
1	BoronIBA 12/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2016
1	Volatile Oils (Essential Oils)IBA 07/2016
1	CosmeticsIBA 01/2016
1	PolymersIBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	Antimalarials (Antimalarial Agents)IBA 01/2016
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 12/2015

Therapy/Procedure

15	Therapeutics 12/2017 - 08/2003
4	Drug Therapy (Chemotherapy) 03/2011 - 05/2003
1	Aftercare (After-Treatment) 12/2016